Semaglutida oral na doença hepática esteatótica metabólica em DM2 - Luciano Giacaglia - #Podcast 276

Nov 11, 2024

Autor: Luciano Giacaglia

Revista: Diabetes Obes Metab.

Ref: Arai T. Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational study. Diabetes Obes Metab. 2024 Nov;26(11):4958-4965. doi: 10.1111/dom.15898.